Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

7.410 +0.130 (+1.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,551,254
Open 7.100
Bid (Size) 7.040 (3)
Ask (Size) 8.330 (5)
Prev. Close 7.280
Today's Range 7.080 - 7.470
52wk Range 6.080 - 19.11
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer
From NeoGenomics, Inc.
Via Business Wire
Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could... 
Via StockStory
Topics Bonds Stocks
Exposures Debt Markets US Equities

Performance

YTD
-55.1%
-55.1%
1 Month
-26.6%
-26.6%
3 Month
-33.7%
-33.7%
6 Month
-56.2%
-56.2%
1 Year
-48.0%
-48.0%

More News

Read More
NeoGenomics to Participate in Upcoming June Investor Conferences
From NeoGenomics, Inc.
Via Business Wire
A Look at NeoGenomics's Upcoming Earnings Report
Via Benzinga
Earnings Scheduled For April 29, 2025
Via Benzinga
Insights Ahead: NeoGenomics's Quarterly Earnings
Via Benzinga
3 Healthcare Stocks with Mounting Challenges
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
3 Russell 2000 Stocks in the Doghouse
Via StockStory
NEO Q1 Earnings Call: Sales Growth, Pharma Headwinds, and Pathline Integration Shape Outlook
Via StockStory
Earnings Scheduled For May 9, 2025
Via Benzinga
Assessing NeoGenomics: Insights From 9 Financial Analysts
Via Benzinga
It's Not Too Late to Jump on These Under-the-Radar Momentum Plays
Via MarketBeat
Topics World Trade
Exposures Tariff
3 Small-Cap Stocks Walking a Fine Line
Via StockStory
NeoGenomics Pays Off 1.25% Convertible Senior Notes
From NeoGenomics, Inc.
Via Business Wire
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
Why NeoGenomics (NEO) Stock Is Nosediving
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Keep an eye on the top gainers and losers in Tuesday's session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings
Via Benzinga
Exposures Fossil Fuels
NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops
Via StockStory
NeoGenomics Reports First Quarter 2025 Results
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For
Via StockStory
Topics Artificial Intelligence World Trade
Exposures Artificial Intelligence Tariff

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 7.410
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 05/23/25 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 910.07M
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 910M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.